Bariatric surgeon Dr Vivek Bindal on where weight loss drugs fit next to surgery

More peptides

1. FDA clears Novo Nordisk's weekly insulin Awiqli for kids 10 and up with type 2

   

   AHad-hoc-news.de Oct 24

   peptides typeshitNews

   FDA clears Novo Nordisk's weekly insulin Awiqli for kids 10 and up with type 2

   Novo also reported 25% average weight loss in women on CagriSema in a post-hoc trial analysis, while BMO flagged Ozempic losing US share.

   Read at ad-hoc-news.de
2. Obesity doctor Spencer Nadolsky reacts to a comedian's take on GLP-1 drugs

   

   D@drnadolsky Oct 23

   peptides typeshitNews

   Obesity doctor Spencer Nadolsky reacts to a comedian's take on GLP-1 drugs

   Dr. Nadolsky responds to a clip from comedian @stavvybaby2 about GLP-1s, adding a doctor's view to the joke.

   See it on Instagram
3. Anonymous Fesshole confession says grief covered for secret Ozempic weight loss

   

   FFesshole🧻 Oct 23

   peptides typeshitNews

   Anonymous Fesshole confession says grief covered for secret Ozempic weight loss

   An anonymous poster says people put their dramatic weight loss down to their mother's death, when it was really Ozempic they wanted to keep quiet.

   See it on X
4. Abhi says semaglutide is only the first step in the GLP-1 pharma opportunity

   

   SA@socho.abhi Oct 23

   peptides typeshitNews

   Abhi says semaglutide is only the first step in the GLP-1 pharma opportunity

   A short social post frames the semaglutide molecule as the start of a bigger business story for drugmakers, with a note that it is not medical advice.

   See it on Instagram
5. FDA recalls 23 compounded GLP-1 vials from Apothecary Pharma LLC over sterility

   

   P@pix11news Oct 24

   peptides typeshitSafety

   FDA recalls 23 compounded GLP-1 vials from Apothecary Pharma LLC over sterility

   PIX11 reports the recall covers 23 compounded GLP-1 vials because there is no assurance they are sterile. Check the list if you use compounded shots.

   See it on Instagram
6. Benjamin Bikman credits lower insulin, not direct anti-aging, for a tirzepatide finding

   

   BBBenjamin Bikman Oct 24

   peptides typeshitResearch

   Benjamin Bikman credits lower insulin, not direct anti-aging, for a tirzepatide finding

   Bikman welcomes a new result but argues the likely cause is tirzepatide bringing insulin down rather than the drug slowing aging itself. His view, not a study claim.

   See it on X